Johnson & Johnson Acquire Actelion Ltd.

News   Jan 27, 2017 | Original Story From Johnson & Johnson

 
Johnson & Johnson Acquire Actelion Ltd.
 
 
 

RELATED ARTICLES

Understanding Lung Cancer Cell Networks Helps Create Drug Treatments

News

A team of scientists has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.

READ MORE

XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery Services

News

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.

READ MORE

BioAscent Establishes Integrated Drug Discovery Services Offering

News

Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE